V
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Recent Filings
- S-13.1 MBUrigen Pharmaceuticals, Inc.Feb 11, 5:26 PM ET·0001144204-15-008021
- 8-K35.4 KBUrigen Pharmaceuticals, Inc.Oct 5, 4:21 PM ET·0001013762-12-001903
- 8-K24.0 KBUrigen Pharmaceuticals, Inc.Sep 12, 5:25 PM ET·0001013762-12-001809
- 10-K3.6 MBUrigen Pharmaceuticals, Inc.Aug 10, 5:23 PM ET·0001013762-12-001571
- 8-K32.9 KBUrigen Pharmaceuticals, Inc.Jun 7, 5:20 PM ET·0001013762-12-001292
- 8-K833.6 KBUrigen Pharmaceuticals, Inc.Jan 10, 4:45 PM ET·0001013762-12-000046
- 8-K24.5 KBUrigen Pharmaceuticals, Inc.Sep 7, 5:00 PM ET·0001013762-10-002181
- 8-K42.7 KBUrigen Pharmaceuticals, Inc.Jul 6, 5:00 PM ET·0001013762-10-001541
- 10-Q742.0 KBUrigen Pharmaceuticals, Inc.May 17, 2:21 PM ET·0001013762-10-001182
- 8-K445.7 KBUrigen Pharmaceuticals, Inc.May 4, 5:29 PM ET·0001013762-10-001008
Insiders
10- ALTSCHUL ARTHUR G JR10% Owner
- DELTA OPPORTUNITY FUND LTD10% Owner
- DIAZ & ALTSCHUL CAPITAL MANAGEMENT LLC10% Owner
- DIAZ REINALDO MDirector
- ENRIGHT PATRICK GDirector
- Garner William JDirector, Chief Executive Officer, 10% Owner
- GOLDBERG MICHAEL MDirector
- GREAT POINT PARTNERS LLC10% Owner
- JAY JEFFREY R10% Owner
- LASEZKAY GEORGE MDirector
Tickers
No tickers on record
Addresses
business
317 GEORGE STREET SUITE 400
NEW BRUNSWICK, NJ, 08901
mailing
317 GEORGE STREET SUITE 400
NEW BRUNSWICK, NJ, 08901
Former Names
- Urigen Pharmaceuticals, Inc.2020-11-20
- VALENTIS INC2007-07-31
- MEGABIOS CORP1999-02-24